Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1979 Jun;36(3):449–455.

The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.

J Mertin, A Stackpoole
PMCID: PMC1537739  PMID: 487646

Abstract

In this paper we report a study of the effects of splenectomy on the immunosuppressive action of essential fatty acids (EFA) which is thought to be mediated through prostaglandins (PG) produced in the spleen. Experimental allergic encephalomyelitis (EAE) was induced in normal, splenectomized and sham splenectomized Lewis rats. EFA were administered orally, the animals in the control groups being treated with liquid paraffin. Treatment with EFA significantly suppressed clinical disease in those animals in which EAE was induced by the inoculation of central nervous system material of guinea-pigs or by passive transfer by Con A-stimulated spleen cells. Splenectomy abrogated the suppressive effect of EFA. This observation, together with previous results showing the abrogation of EFA immunosuppression by an inhibitor of the biosynthesis of PG from EFA, led us to postulate a close relationship between EFA, PG and a splenic factor suppressing immunopathological mechanisms in EAE.

Full text

PDF
449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adda D. H., Beraud E., Depieds R. Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis. Eur J Immunol. 1977 Sep;7(9):620–623. doi: 10.1002/eji.1830070908. [DOI] [PubMed] [Google Scholar]
  2. Arnason B. G., Antel J. Suppressor cell function in multiple sclerosis. Ann Immunol (Paris) 1978 Feb-Mar;129(2-3):159–170. [PubMed] [Google Scholar]
  3. Bates D., Fawcett P. R., Shaw D. A., Weightman D. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J. 1978 Nov 18;2(6149):1390–1391. doi: 10.1136/bmj.2.6149.1390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coons T. A., Goldberg E. H. Rejection of male skin grafts by splenectomized female mice. Science. 1978 Apr 21;200(4339):320–321. doi: 10.1126/science.345443. [DOI] [PubMed] [Google Scholar]
  5. Jacobson E. B., Herzenberg L. A., Riblet R., Herzenberg L. A. Active suppression of immunoglobulin allotype synthesis. II. Transfer of suppressing factor with spleen cells. J Exp Med. 1972 May 1;135(5):1163–1176. doi: 10.1084/jem.135.5.1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McFarlin D. E., Blank S. E., Kibler R. F. Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol. 1974 Aug;113(2):712–715. [PubMed] [Google Scholar]
  7. McIlhenny H. M., Levine S., Wiseman E. H., Sowinski R. Disposition and activity in experimental allergic encephalomyelitis of flumizole, a nonacidic, nonsteroidal, anti-inflammatory agent. Exp Neurol. 1978 Jan 1;58(1):126–137. doi: 10.1016/0014-4886(78)90128-0. [DOI] [PubMed] [Google Scholar]
  8. Meade C. J., Mertin J. Fatty acids and immunity. Adv Lipid Res. 1978;16:127–165. doi: 10.1016/b978-0-12-024916-9.50008-1. [DOI] [PubMed] [Google Scholar]
  9. Meade C. J., Mertin J., Sheena J., Hunt R. Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig. J Neurol Sci. 1978 Feb;35(2-3):291–308. doi: 10.1016/0022-510x(78)90010-2. [DOI] [PubMed] [Google Scholar]
  10. Mertin J. Effect of polyunsaturated fatty acids on skin allograft survival and primary and secondary cytotoxic response in mice. Transplantation. 1976 Jan;21(1):1–4. doi: 10.1097/00007890-197601000-00001. [DOI] [PubMed] [Google Scholar]
  11. Mertin J., Hughes D. Specific inhibitory action of polyunsaturated fatty acids on lymphocyte transformation induced by PHA and PPD. Int Arch Allergy Appl Immunol. 1975;48(2):203–210. doi: 10.1159/000231306. [DOI] [PubMed] [Google Scholar]
  12. Mertin J., Hunt R. Influence of polyunsaturated fatty acids on survival of skin allografts and tumor incidence in mice. Proc Natl Acad Sci U S A. 1976 Mar;73(3):928–931. doi: 10.1073/pnas.73.3.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mertin J., Meade C. J. Relevance of fatty acids in multiple sclerosis. Br Med Bull. 1977 Jan;33(1):67–71. doi: 10.1093/oxfordjournals.bmb.a071399. [DOI] [PubMed] [Google Scholar]
  14. Mertin J., Stackpoole A. Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin. Prostaglandins Med. 1978 Oct;1(4):283–291. doi: 10.1016/0161-4630(78)90047-2. [DOI] [PubMed] [Google Scholar]
  15. Mihas A. A., Gibson R. G., Hirschowitz B. I. Suppression of lymphocyte transformation by 16, (16) dimethyl prostaglandin E2 and unsaturated fatty acids. Proc Soc Exp Biol Med. 1975 Sep;149(4):1026–1028. doi: 10.3181/00379727-149-38949. [DOI] [PubMed] [Google Scholar]
  16. Millar J. H., Zilkha K. J., Langman M. J., Wright H. P., Smith A. D., Belin J., Thompson R. H. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J. 1973 Mar 31;1(5856):765–768. doi: 10.1136/bmj.1.5856.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moorhead J. W. Subpopulations of mouse T lymphocytes. II. Suppression of graft-vs.-host reactions by naturally proliferating splenic T cells. Eur J Immunol. 1978 Mar;8(3):163–167. doi: 10.1002/eji.1830080304. [DOI] [PubMed] [Google Scholar]
  18. Osheroff P. L., Webb D. R., Paulsrud J. Induction of T-cell dependent splenic prostaglandin F2alpha by T-cell dependent antigen. Biochem Biophys Res Commun. 1975 Sep 2;66(1):425–429. doi: 10.1016/s0006-291x(75)80345-7. [DOI] [PubMed] [Google Scholar]
  19. PATERSON P. Y., DIDAKOW N. C. Transfer of allergic encephalomyelitis using splenectomized albino rats. Proc Soc Exp Biol Med. 1961 Dec;108:768–771. doi: 10.3181/00379727-108-27061. [DOI] [PubMed] [Google Scholar]
  20. Panitch H. S., McFarlin D. E. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J Immunol. 1977 Sep;119(3):1134–1137. [PubMed] [Google Scholar]
  21. Pelus L. M., Strausser H. R. Prostaglandins and the immune response. Life Sci. 1977 Mar 15;20(6):903–913. doi: 10.1016/0024-3205(77)90274-0. [DOI] [PubMed] [Google Scholar]
  22. Raine C. S., Traugott U., Stone S. H. Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis. Science. 1978 Aug 4;201(4354):445–448. doi: 10.1126/science.78524. [DOI] [PubMed] [Google Scholar]
  23. Sampson D., Kauffman H. M., Jr, Grotelueschen C., Metzig J. Suppressor activity of the human spleen and thymus. Surgery. 1976 Apr;79(4):393–397. [PubMed] [Google Scholar]
  24. Traugott U., Stone S. H., Raine C. S. Experimental allergic encephalomyelitis--migration of early T cells from the circulation into the central nervous system. J Neurol Sci. 1978 Mar;36(1):55–61. doi: 10.1016/0022-510x(78)90161-2. [DOI] [PubMed] [Google Scholar]
  25. Vane J. R. The mode of action of aspirin and similar compounds. J Allergy Clin Immunol. 1976 Dec;58(6):691–712. doi: 10.1016/0091-6749(76)90181-0. [DOI] [PubMed] [Google Scholar]
  26. Webb D. R., Nowowiejski I. Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity. Cell Immunol. 1978 Nov;41(1):72–85. doi: 10.1016/s0008-8749(78)80029-x. [DOI] [PubMed] [Google Scholar]
  27. Webb D. R., Osheroff P. L. Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1300–1304. doi: 10.1073/pnas.73.4.1300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Weyman C., Morgan S. J., Belin J., Smith A. D. Phytohaemagglutinin stimulation of human lymphocytes: effect of fatty acids on uridine uptake and phosphoglyceride fatty acid profile. Biochim Biophys Acta. 1977 Jan 24;496(1):155–166. doi: 10.1016/0304-4165(77)90123-4. [DOI] [PubMed] [Google Scholar]
  29. Wiśniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann Neurol. 1977 Feb;1(2):144–148. doi: 10.1002/ana.410010207. [DOI] [PubMed] [Google Scholar]
  30. Zurier R. B., Sayadoff D. M., Torrey A. B., Rothfield N. F. Prostaglandin E treatment of NZB/NZW mice. Arthritis Rheum. 1977 Mar;20(2):723–728. doi: 10.1002/art.1780200213. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES